Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR Imaging to Stratify Prostate Cancer Progression Risk in Patients on Active Surveillance

NCT00796874 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT00796874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00796874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR Imaging to Stratify Prostate Cancer Progression Risk in Patients on Active Surveillance
Lead sponsor
Roswell Park Cancer Institute
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2008
Completion date
July 31, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer